Date : 23 Apr 25
Pfizer Faces New Competition in ATTR-CM Market as Alnylam and BridgeBio Enter the Fray.
Pfizer's dominance in the ATTR-CM treatment market is challenged as Alnylam and Bridg...
Bristol Myers Squibb Faces Setback as Cobenfy Falls Short in Schizophrenia Trial.
Bristol Myers Squibb’s schizophrenia treatment Cobenfy has failed to meet its primary...
Single Psychedelic Dose Boosts Mice's Brain Flexibility for Weeks, Study Finds.
A new University of Michigan study reveals that one dose of a psychedelic compound si...
Seven Biotechs Racing Toward a Cure for Chronic Hepatitis B.
As chronic hepatitis B continues to affect millions worldwide, seven biotech companie...
Study Reveals How Family and Culture Shape Body Image in Young Women.
A new international study highlights how family dynamics and cultural backgrounds inf...
Gene Syntax Found to Influence Expression and Stability in Synthetic Plasmids.
A new study by Dartmouth College reveals that the order and orientation of genes—refe...
Pioneering Conservation Efforts: UC San Diego Researcher Sheds Light on Wild Elephant Survival.
In honor of Earth Day 2025, UC San Diego's Dr. Shermin de Silva highlights her ground...
Global Coral Bleaching Crisis: 84% of Reefs Affected in Record-Setting Event.
The world's coral reefs are facing an unprecedented bleaching event, with 84% of reef...
Please Accept Cookies for Better Performance